NIAID Launches First Clinical Trial to Test Antibody-Drug Combination for Long-Acting HIV Treatment | ||
The first clinical trial to test the combination of a long-acting anti-HIV drug plus a powerful HIV antibody as a long-acting treatment for people living with HIV has begun... | ||
|
jueves, 23 de enero de 2020
NIAID Launches First Clinical Trial to Test Antibody–Drug Combination for Long-Acting HIV Treatment | HIV.gov
NIAID Launches First Clinical Trial to Test Antibody–Drug Combination for Long-Acting HIV Treatment | HIV.gov
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario